Generic placeholder image

Current Genomics

Editor-in-Chief

ISSN (Print): 1389-2029
ISSN (Online): 1875-5488

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions

Author(s): Marek Drozdzik, Monika Bialecka and Mateusz Kurzawski

Volume 14, Issue 8, 2013

Page: [568 - 577] Pages: 10

DOI: 10.2174/1389202914666131210212521

Price: $65

Abstract

In the last years due to development of molecular methods a substantial progress in understanding of genetic associations with drug effects in many clinical disciplines has been observed. The efforts to define the role of genetic polymorphisms in optimizing pharmacotherapy of Parkinson’s disease (PD) were also undertaken. So far, some promising genetic loci for PD treatment were determined. In the review pharmacogenetic aspects of levodopa, dopamine agonists and COMT inhibitors are discussed.

Keywords: Parkinson's disease, Pharmacogenetics, Genetic polymorphism.

« Previous

Rights & Permissions Print Export Cite as
© 2024 Bentham Science Publishers | Privacy Policy